Back

Is there a role of isoproterenol testing in the electrical or concealed phase of arrhythmogenic right ventricular cardiomyopathy as a cardiologist’s nightmare?

EP Europace Journal

7 June 2018
Organised by: Logo
Read full article
ESC Journals

Contributors

Ozcan Ozeke
Ozcan Ozeke

Author

Ankara City Hospital Ankara , Turkiye

Serkan Cay
Serkan Cay

Author

Firat Ozcan
Firat Ozcan

Author

Serkan Topaloglu
Serkan Topaloglu

Author

Dursun Aras
Dursun Aras

Author

You may be interested in
thumbnail
Congress Presentation
Isoproterenol testing as a risk stratification tool in arrhythmogenic mitral valve prolapse
30 August 2025
thumbnail
Congress Presentation
Characterization and modelling of the abnormal electrophysiological response under beta-adrenergic stimulation in hypertrophic cardiomyopathy
23 April 2021
thumbnail
Congress Session
When the rhythm is of the essence
18 May 2025
thumbnail
Congress Presentation
The utility of the 1994 versus the revised 2010 arrhythmogenic right ventricular cardiomyopathy (ARVC) task force diagnostic criteria for identifying mutation-positive probands with ARVC
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources